India Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

India Pharmaceuticals and Healthcare Report

India Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
India Pharmaceuticals and Healthcare Report
Published Aug 06, 2016
121 pages — Published Aug 06, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In April ----, the Indian government reported that pharmaceutical exports from India have increased by -.- in the last fiscal year while exports to the US rose by -- y-o-y. Volume wise, the country accounts for -- of the world s generic medicines, making it the largest generic drug maker globally. ...Volume wise, the country accounts for -- of the world s generic medicines, making it the largest generic drug maker globally. In May ----, the Indian government approved a new intellectual property rights policy that it said would encourage innovation and improve access to healthcare. Critically, the policy continues to allow compulsory licensing while key provisions such as Section -d of the Patent Act remain in force. ...This follows a move by Reliance Life Sciences to launch its copy of Avastin in June ----. Roche had filed a lawsuit to block the launch of Hetero s biosimilar but the firm noted that because no injunction order has been given, the launch is not prohibited.

...In line with our expectations, the Reserve Bank of India lowered its repo rate by -- basis points (bps) to -.-- at its April - monetary policy meeting, while also stating its aim to improve the transmission mechanism through various policy adjustments to its liquidity management framework. We maintain our forecast for the central bank to lower its key policy rate by an additional --bps to -.-- by the end of FY----/-- (April-March) in a bid to provide continued support to the economy. ...In line with our expectations, the Reserve Bank of India lowered its repo rate by -- basis points (bps) to -.-- at its April - monetary policy meeting, while also stating its aim to improve the transmission mechanism through various policy adjustments to its liquidity management framework. We maintain our forecast for the central bank to lower its key policy rate by an additional --bps to -.-- by the end of FY----/-- (April-March) in a bid to provide continued support to the economy. The central bank remained dovish in its statement, and subdued inflation in FY----/-- will provide sufficient room for a reduction in the repo rate. ...We maintain our forecast for the central bank to lower its key policy rate by an additional --bps to -.-- by the end of FY----/-- (April-March) in a bid to provide continued support to the economy. The central bank remained dovish in its statement, and subdued inflation in FY----/-- will provide sufficient room for a reduction in the repo rate.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...

  
Source:
Document ID
1748-1937
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "India Pharmaceuticals and Healthcare Report" Aug 06, 2016. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/India-Pharmaceuticals-and-Healthcare-Report-2026-114>
  
APA:
Business Monitor International - Industry Reports. (2016). India Pharmaceuticals and Healthcare Report Aug 06, 2016. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/India-Pharmaceuticals-and-Healthcare-Report-2026-114>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.